In December, Ariad ($ARIA) won an accelerated FDA approval for Iclusig (ponatinib), a leukemia treatment analysts say could be a blockbuster for the Massachusetts drugmaker. Now, contract manufacturer Ash Stevens has signed on to manufacture the drug's API. Report